Hospital Profile
Name | Alexian Brothers Medical Center 1 |
---|
Type | Acute Care Hospital |
---|
Location | 800 W Biesterfield Rd, Elk Grove Village, Illinois |
---|
Ownership | Voluntary non-profit - Church |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 140258 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Alexian Brothers Medical Center 1 from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1265577191 |
Organization Name | ALEXIAN BROTHERS MEDICAL CENTER |
Address | 800 Biesterfield Rd, Elk Grove Village, IL 60007 |
Hospital Type | General Acute Care Hospital |
Phone Number | 847-437-5500 |
News Archive
Discovery enables scientists to devise novel strategies to diagnose and treat brain cancer
A team of Columbia scientists have discovered two genes that, when simultaneously activated, are responsible for the most aggressive forms of human brain cancer.
Quality of life measures most useful for clinical decision-making in trials with QOL as primary outcome
Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Cancer Institute.
Scotland-based virtual tissue biobank plays key role in the battle against COVID-19
A Scotland-based virtual biobank dealing in ethically sourced human tissue samples is helping to speed up the provision of COVID-19 samples for researchers and drug developers working to find a cure for the global pandemic.
Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals
Meda has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the agreement, Meda is taking over full responsibility for development and commercialization of the compound. Flupirtine is currently in phase II development for the patented indication fibromyalgia.
Read more Medical News
› Verified 7 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Discovery enables scientists to devise novel strategies to diagnose and treat brain cancer
A team of Columbia scientists have discovered two genes that, when simultaneously activated, are responsible for the most aggressive forms of human brain cancer.
Quality of life measures most useful for clinical decision-making in trials with QOL as primary outcome
Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Cancer Institute.
Scotland-based virtual tissue biobank plays key role in the battle against COVID-19
A Scotland-based virtual biobank dealing in ethically sourced human tissue samples is helping to speed up the provision of COVID-19 samples for researchers and drug developers working to find a cure for the global pandemic.
Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals
Meda has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the agreement, Meda is taking over full responsibility for development and commercialization of the compound. Flupirtine is currently in phase II development for the patented indication fibromyalgia.
Read more News
› Verified 7 days ago